Toda, Japan

Tsutomu Mimoto


Average Co-Inventor Count = 4.8

ph-index = 5

Forward Citations = 47(Granted Patents)


Location History:

  • Tokyo, JP (1997)
  • Saitama, JP (2001 - 2002)
  • Toda, JP (1999 - 2004)
  • Osaka, JP (2010)

Company Filing History:


Years Active: 1997-2010

Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Tsutomu Mimoto

Introduction

Tsutomu Mimoto is a prominent inventor based in Toda, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating serious diseases. With a total of 10 patents to his name, Mimoto's work has had a substantial impact on medical research and treatment options.

Latest Patents

One of Mimoto's latest patents is a β-secretase inhibitor, which relates to a compound designed to prevent or treat Alzheimer's disease. This invention includes a complex formula that outlines various chemical groups and their configurations. Another notable patent involves dipeptide compounds that serve as antiviral agents, showcasing his versatility in addressing different health challenges.

Career Highlights

Throughout his career, Mimoto has worked with reputable companies such as Japan Energy Corporation and Sumitomo Pharmaceuticals Company Limited. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Mimoto has collaborated with esteemed colleagues, including Yoshiaki Kiso and Makoto Shintani. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the quality of his inventions.

Conclusion

Tsutomu Mimoto's innovative work in pharmaceuticals has led to significant advancements in the treatment of diseases like Alzheimer's. His dedication to research and collaboration with other experts underscores his commitment to improving healthcare through innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…